These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 19936990)
81. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. Snitkovsky S; Niederman TM; Mulligan RC; Young JA J Virol; 2001 Feb; 75(3):1571-5. PubMed ID: 11152532 [TBL] [Abstract][Full Text] [Related]
82. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634 [TBL] [Abstract][Full Text] [Related]
83. [Construction of HBD-3 gene mammary-specific expression vector and eukaryotic expression]. Peng W; Lan Z; Ma J; Wang B; Zhang Y Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):968-74. PubMed ID: 19835135 [TBL] [Abstract][Full Text] [Related]
84. Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Ikawa M; Tanaka N; Kao WW; Verma IM Mol Ther; 2003 Oct; 8(4):666-73. PubMed ID: 14529840 [TBL] [Abstract][Full Text] [Related]
85. Construction of La-tPA vector and expression in the mammary gland of transgenic mice. Lu Y; Deng J; Cheng X; Zhou J; Huang P Chin J Biotechnol; 1999; 15(2):99-103. PubMed ID: 10719629 [TBL] [Abstract][Full Text] [Related]
86. Reversible transdifferentiation of secretory epithelial cells into adipocytes in the mammary gland. Morroni M; Giordano A; Zingaretti MC; Boiani R; De Matteis R; Kahn BB; Nisoli E; Tonello C; Pisoschi C; Luchetti MM; Marelli M; Cinti S Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16801-6. PubMed ID: 15556998 [TBL] [Abstract][Full Text] [Related]
87. Advances in lentiviral vectors: a patent review. Picanco-Castro V; de Sousa Russo-Carbolante EM; Tadeu Covas D Recent Pat DNA Gene Seq; 2012 Aug; 6(2):82-90. PubMed ID: 22670608 [TBL] [Abstract][Full Text] [Related]
88. Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy. Haricharan S; Dong J; Hein S; Reddy JP; Du Z; Toneff M; Holloway K; Hilsenbeck SG; Huang S; Atkinson R; Woodward W; Jindal S; Borges VF; Gutierrez C; Zhang H; Schedin PJ; Osborne CK; Tweardy DJ; Li Y Elife; 2013 Dec; 2():e00996. PubMed ID: 24381245 [TBL] [Abstract][Full Text] [Related]
89. Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice. Bu W; Creighton CJ; Heavener KS; Gutierrez C; Dou Y; Ku AT; Zhang Y; Jiang W; Urrutia J; Jiang W; Yue F; Jia L; Ibrahim AA; Zhang B; Huang S; Li Y Sci Adv; 2023 May; 9(19):eade0059. PubMed ID: 37172086 [TBL] [Abstract][Full Text] [Related]
90. In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection. Bu W; Li Y J Vis Exp; 2023 Feb; (192):. PubMed ID: 36847377 [TBL] [Abstract][Full Text] [Related]
91. STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Lin M; Ku AT; Dong J; Yue F; Jiang W; Ibrahim AA; Peng F; Creighton CJ; Nagi C; Gutierrez C; Rosen JM; Zhang XH; Hilsenbeck SG; Chen X; Du YN; Huang S; Shi A; Fan Z; Li Y Oncogene; 2022 Nov; 41(48):5214-5222. PubMed ID: 36261627 [TBL] [Abstract][Full Text] [Related]
92. High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array. Wang X; Shi Z; Lu HY; Kim JJ; Bu W; Villalobos JA; Perera DN; Jung SY; Wang T; Grimm SL; Taylor BC; Rajapakshe K; Park H; Wulfkuhle J; Young NL; Li Y; Coarfa C; Edwards DP; Huang S J Proteomics; 2022 Jun; 262():104596. PubMed ID: 35489683 [TBL] [Abstract][Full Text] [Related]
93. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Young A; Bu W; Jiang W; Ku A; Kapali J; Dhamne S; Qin L; Hilsenbeck SG; Du YN; Li Y Cancer Prev Res (Phila); 2022 Jan; 15(1):3-10. PubMed ID: 34667127 [TBL] [Abstract][Full Text] [Related]
94. Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast. Sinha VC; Rinkenbaugh AL; Xu M; Zhou X; Zhang X; Jeter-Jones S; Shao J; Qi Y; Zebala JA; Maeda DY; McAllister F; Piwnica-Worms H Nat Commun; 2021 Aug; 12(1):5024. PubMed ID: 34408137 [TBL] [Abstract][Full Text] [Related]
95. Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo. Bu W; Li Y J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):389-396. PubMed ID: 33165800 [TBL] [Abstract][Full Text] [Related]
96. Breast cancer animal models and applications. Zeng L; Li W; Chen CS Zool Res; 2020 Sep; 41(5):477-494. PubMed ID: 32629551 [TBL] [Abstract][Full Text] [Related]
97. Embryonic Barcoding of Equipotent Mammary Progenitors Functionally Identifies Breast Cancer Drivers. Ying Z; Beronja S Cell Stem Cell; 2020 Mar; 26(3):403-419.e4. PubMed ID: 32059806 [TBL] [Abstract][Full Text] [Related]
98. Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers. Chen CH; Yang N; Zhang Y; Ding J; Zhang W; Liu R; Liu W; Chen C Int J Biol Sci; 2019; 15(8):1733-1742. PubMed ID: 31360115 [TBL] [Abstract][Full Text] [Related]
99. Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes. Bu W; Liu Z; Jiang W; Nagi C; Huang S; Edwards DP; Jo E; Mo Q; Creighton CJ; Hilsenbeck SG; Leavitt AD; Lewis MT; Wong STC; Li Y Cancer Res; 2019 Jan; 79(1):61-71. PubMed ID: 30401712 [TBL] [Abstract][Full Text] [Related]
100. Mouse models in the era of large human tumour sequencing studies. de Ruiter JR; Wessels LFA; Jonkers J Open Biol; 2018 Aug; 8(8):. PubMed ID: 30111589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]